Research Article
Twelve-Year Follow-Up of Laser In Situ Keratomileusis for Moderate to High Myopia
Table 2
Summary for long-term clinical outcomes of conventional laser in situ keratomileusis (LASIK).
| Author Year | Excimer laser | Eyes | Follow-up (years) | Mean Age (years) | Mean spherical equivalent (D) | Safety index | Efficacy index | Predictability within ±1.0 D (%) | Myopic regression (D) | Retreatment (%) |
| Alió et al. 2009 | VISX 20/20 | 34 | 10 | 29.4 | −8.30 | 1.11 | 0.95 | 88 | −0.97 3 months to 10 years | 18 | Alió et al. 2008 | VISX 20/20 | 97 | 10 | 33.2 | −7.27 | 1.08 | 0.88 | 73 | −1.04 3 months to 10 years | 20.6 | Alió et al. 2008 | VISX 20/20 | 196 | 10 | 32.9 | −13.95 | 1.21 | 0.77 | 42 | −1.83 3 months to 10 years | 27.5 | Kymionis et al. 2007 | MEL 60 | 11 | 11 | 41.7 | −12.96 | N.A. | N.A. | 55 | −1.14 | 0 | Rosman et al. 2011 | VISX 20/20 | 126 | 10 | 33.7 | −14.33 | 1.20 | 0.84 | 42 | −1.86 3 months to 10 years | 28.6 | Oruçoğlu et al. 2012 | Keracor | 36 | ≥10 | N.A. | −21.7 | 1.48 | 0.29 | 10 within ±2.0 D | −6.09 | N.A. | Alió et al. 2015 | VISX 20/20 | 40 | 15 | 51.1 | −9.47 | 1.23 | 0.95 | 46 | −1.66 3 months to 15 years | 30.8 | Lim et al. 2016 | VISX S4 | 36 | 10 | 26.6 | −5.73 | 0.99 | 0.73 | 68 | −1.09 | 0 (excluded) | Current | VISX STAR S2 | 68 | 12 | 34.4 | −6.70 | 1.09 | 0.67 | 75 | −0.74 3 months to 12 years | 17.6 |
|
|
D = diopter, N.A. = not applicable.
|